ClinicalTrials.govpublic full text
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
muscular diseases, neuromuscular manifestations, autoimmune, autoimmune diseases, autoimmune diseases of the nervous system, myasthenia gravis, muscle weakness, arc-311, cart, car-t, bcma, anito-cel
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1046971
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.